- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
----------------
SCHEDULE 14D-1
TENDER OFFER STATEMENT PURSUANT TO SECTION 14(D)(1)
OF THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 8)
----------------
MCKESSON CORPORATION
(NAME OF SUBJECT COMPANY)
ECO ACQUISITION CORPORATION
A WHOLLY OWNED SUBSIDIARY OF
ELI LILLY AND COMPANY
(BIDDERS)
COMMON STOCK, $2.00 PAR VALUE PER SHARE 581556 10 7
(INCLUDING THE ASSOCIATED RIGHTS) (CUSIP NUMBER OF CLASS OF SECURITIES)
(TITLE OF CLASS OF SECURITIES)
J.B. KING, ESQ.
VICE PRESIDENT AND GENERAL COUNSEL
ELI LILLY AND COMPANY
LILLY CORPORATE CENTER
INDIANAPOLIS, INDIANA 46285
(317) 276-2000
(NAMES, ADDRESSES AND TELEPHONE NUMBERS OF PERSONS AUTHORIZED
TO RECEIVE NOTICES AND COMMUNICATIONS ON BEHALF OF BIDDER)
WITH A COPY TO:
BERNARD E. KURY, ESQ.
DEWEY BALLANTINE
1301 AVENUE OF THE AMERICAS
NEW YORK, NEW YORK 10019
(212) 259-7400
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
This Amendment No. 8 to the Schedule 14D-1 relates to a tender offer by ECO
Acquisition Corporation (the "Purchaser"), a Delaware corporation and a wholly
owned subsidiary of Eli Lilly and Company, an Indiana corporation ("Parent"),
to purchase all outstanding shares of common stock, par value $2.00 per share
and the associated Rights (as defined in the Offer to Purchase) (collectively,
the "Shares"), of McKesson Corporation (the "Company"), a Delaware corporation,
at a purchase price of $76.00 per Share, net to the seller in cash, without
interest, upon the terms and subject to the conditions set forth in the Offer
to Purchase, dated July 15, 1994 (the "Offer to Purchase"), and the related
Letter of Transmittal (which together constitute the "Offer"), copies of which
were attached as Exhibits (a)(1) and (a)(2), respectively, to the Schedule 14D-
1 filed with the Securities and Exchange Commission on July 15, 1994 as amended
by Amendment Nos. 1, 2, 3, 4, 5, 6 and 7 thereto dated July 27, 1994, August
10, 1994, September 7, 1994, September 21, 1994, October 11, 1994, October 13,
1994 and October 14, 1994, respectively (collectively, the "Schedule 14D-1").
The purpose of this Amendment No. 8 is to amend and supplement Items 10 and 11
of the Schedule 14D-1 as described below.
ITEM 10. ADDITIONAL INFORMATION TO BE FURNISHED.
Reference is made to the press release issued by Parent on October 24, 1994,
a copy of which is filed as Exhibit (a)(26) to the Schedule 14D-1 and is
incorporated herein by reference.
ITEM 11. MATERIAL TO BE FILED AS EXHIBITS.
(a)(26) --Form of press release issued by Parent on October 24, 1994.
1
SIGNATURE
AFTER DUE INQUIRY AND TO THE BEST OF ITS KNOWLEDGE AND BELIEF, EACH OF THE
UNDERSIGNED CERTIFIES THAT THE INFORMATION SET FORTH IN THIS STATEMENT IS TRUE,
COMPLETE AND CORRECT.
Eli Lilly and Company
/s/ James M. Cornelius
By: _________________________________
Name: James M. Cornelius
Title: Vice President, Finance
and Chief Financial Officer
ECO Acquisition Corporation
/s/ Charles E. Schalliol
By: _________________________________
Name: Charles E. Schalliol
Title: President
Dated: October 24, 1994
2
EXHIBIT (a)(26)
October 24, 1994
For Release Immediately
Refer to (317) 276-3655
LILLY EXTENDS MCKESSON TENDER OFFER
Eli Lilly and Company (NYSE:LLY) announced today that it is extending its
offer to purchase all outstanding shares of common stock of McKesson
Corporation for $76.00 per share in cash until 5:00 p.m., New York City time,
on Monday, November 7, 1994.
The terms of the extended offer are identical to the terms of the original
offer announced on July 11, 1994. Therefore, in addition to Lilly's offer of
$76.00 per share in cash, McKesson Corporation will, immediately prior to the
consummation of the tender offer, distribute to its stockholders one share of
common stock of a newly formed McKesson corporation for each share held in the
old McKesson Corporation.
Lilly said that its discussions with the Federal Trade Commission were
continuing. The mandatory waiting period under the Hart-Scott-Rodino Antitrust
Improvements Act is now scheduled to expire on Thursday, October 27, 1994. It
is possible that Lilly could agree to a further extension of the waiting
period. For this reason, as well as to permit McKesson time to complete the
distribution of stock of the newly formed McKesson corporation to its
stockholders, it is possible that Lilly's tender offer will be further
extended.
As of Friday, October 21, 1994, approximately 15,184,000 shares of McKesson
common stock had been tendered.
* * *